Ardelyx, Inc.

Ardelyx, Inc.verified

ARDX

Price:

$4.7

Market Cap:

$1.11B

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or hear...[Read more]

Industry

Biotechnology

IPO Date

2014-06-19

Stock Exchange

NASDAQ

Ticker

ARDX

The Enterprise Value as of December 2024 (TTM) for Ardelyx, Inc. (ARDX) is 1.17B

According to Ardelyx, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.17B. This represents a change of -31.07% compared to the average of 1.70B of the last 4 quarters.

Ardelyx, Inc. (ARDX) Historical Enterprise Value (quarterly & annually)

How has ARDX Enterprise Value performed in the past?

The mean historical Enterprise Value of Ardelyx, Inc. over the last ten years is 397.23M. The current 1.17B Enterprise Value has changed 29.36% with respect to the historical average. Over the past ten years (40 quarters), ARDX's Enterprise Value was at its highest in in the June 2024 quarter at 1.84B. The Enterprise Value was at its lowest in in the June 2022 quarter at 68.16M.

Quarterly (TTM)
Annual

Average

397.23M

Median

332.80M

Minimum

71.07M

Maximum

1.39B

Ardelyx, Inc. (ARDX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ardelyx, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 403.41%

Maximum Annual Enterprise Value = 1.39B

Minimum Annual Increase = -83.82%

Minimum Annual Enterprise Value = 71.07M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20231.39B255.17%
2022392.59M347.64%
202187.70M-83.82%
2020541.88M51.45%
2019357.80M403.41%
201871.07M-70.10%
2017237.69M-51.99%
2016495.09M60.84%
2015307.81M256.65%
201486.31M-43.91%

Ardelyx, Inc. (ARDX) Average Enterprise Value

How has ARDX Enterprise Value performed in the past?

The current Enterprise Value of Ardelyx, Inc. (ARDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

624.88M

5-year avg

554.87M

10-year avg

397.23M

Ardelyx, Inc. (ARDX) Enterprise Value vs. Peers

How is ARDX’s Enterprise Value compared to its peers?

Ardelyx, Inc.’s Enterprise Value is greater than BioLineRx Ltd. (45.16M), greater than Lexicon Pharmaceuticals, Inc. (337.04M), greater than Seres Therapeutics, Inc. (194.08M), less than ImmunityBio, Inc. (2.54B), less than Zura Bio Limited (0), greater than Hepion Pharmaceuticals, Inc. (-38372349.00), greater than AVROBIO, Inc. (4.18M), greater than Verastem, Inc. (-85302404.00), greater than Mereo BioPharma Group plc (100.05M), greater than Terns Pharmaceuticals, Inc. (502.41M), greater than PDS Biotechnology Corporation (222.09M), greater than Inozyme Pharma, Inc. (36.64M), greater than HOOKIPA Pharma Inc. (209.10M), greater than null (-39352864.00),

Build a custom stock screener for Ardelyx, Inc. (ARDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ardelyx, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ardelyx, Inc. (ARDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ardelyx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Ardelyx, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Ardelyx, Inc. (ARDX)?

What is the 3-year average Enterprise Value for Ardelyx, Inc. (ARDX)?

What is the 5-year average Enterprise Value for Ardelyx, Inc. (ARDX)?

How does the current Enterprise Value for Ardelyx, Inc. (ARDX) compare to its historical average?